Diversified Consumer Services
Company Overview of University of Oxford
University of Oxford is an educational institution that provides undergraduate, graduate, research, and distance learning programs. It offers courses in humanities; physical and life sciences; medical sciences; mathematics; social sciences; archaeology and anthropology; biological sciences; biochemistry; chemistry; and economics and management. The university was founded in 1096 and is based in Oxford, United Kingdom.
Oxford, OX1 2JD
Founded in 1096
Key Executives for University of Oxford
President of Kellogg College at Oxford University and Director of the Department for Continuing Education
Pro-Vice-Chancellor for Planning and Resources
Compensation as of Fiscal Year 2013.
University of Oxford Key Developments
Summit and the University of Oxford Enter Strategic Alliance to Develop Treatments for DMD
Nov 25 13
Summit announced the formation of a strategic alliance with the University of Oxford that will strengthen its utrophin modulator programme for the treatment of the fatal muscle wasting disease, DMD. Summit will acquire exclusive commercial rights to a pipeline of novel, early-stage utrophin modulators and core biological screening technology, and an exclusive option to intellectual property (IP) that is related to the utrophin field generated during the alliance. These assets have been developed at the University of Oxford by research teams led by Professor Kay Davies, an internationally acclaimed expert in DMD, Professor Stephen Davies, the Waynflete Professor of Chemistry and Dr. Angela Russell, an expert in medicinal chemistry and pharmacology. As part of the collaboration, Summit will sponsor a drug discovery programme in the University research laboratories to identify and develop additional utrophin modulator drugs.
Physiomics plc to Collaborate with the University of Oxford and Oxford University Hospitals NHS Trust on Virtual Tumour Clinical Research
Nov 11 13
Physiomics plc announced that it has signed a collaboration agreement with the University of Oxford and Oxford University Hospitals NHS Trust (OUHT) to support the development of Physiomics' flagship Virtual Tumour Clinical technology. Virtual Tumour Clinical is used to predict optimal clinical regimens for cancer trials. Physiomics has been seeking academic and industrial partners to help calibrate the model with key data obtained from such trials. This collaboration is the second such deal to be announced by Physiomics. Under the collaboration agreement, OUHT will provide both calibration and validation data for up to three clinical studies. If this initial phase is successful, the technology will be used to design a clinical study at the OUHT. The research project will commence immediately. At the Oxford Experimental Cancer Medicine Centre the study will be led by Mark Middleton, Professor of Experimental Cancer Medicine at the University of Oxford.
University of Oxford Presents at 25th Annual Canadian Airline Investment Forum, Nov-15-2013 12:45 PM
Nov 11 13
University of Oxford Presents at 25th Annual Canadian Airline Investment Forum, Nov-15-2013 12:45 PM. Venue: Toronto, Ontario, Canada. Speakers: Roy Goode, Emeritus Professor of Law.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries